Medical devices
10 medical device clinical affairs experts
These ten professionals have led clinical affairs in their own roles at medical device companies. A reader can learn how device makers plan and run the clinical studies and evidence work behind their products.
Professionals to explore
01—10Andrew Tummon
LinkedInExperience: Director Of Clinical Affairs · Integra LifeSciences
Director Of Clinical Affairs at Integra LifeSciences since 2011 and former Director of Clinical Affairs at Orthofix (2007–2010). The profile describes implementing and executing medical device clinical trials, with experience in study site management, regulatory requirements, training, consultant management and contract negotiation.
Anna K. Gawlicka
LinkedInExperience: Vice President Clinical Affairs · Pulmonx Corporation
Former Vice President Clinical Affairs at Pulmonx Corporation (2022–2024) and at Medtronic (2021–2022), and Senior Vice President, Clinical & Regulatory Affairs at Averto Medical, Inc since 2026, where the profile says this person leads global clinical and regulatory strategy and execution for the ColoSeal™ Intraluminal Colonic Diversion (ICD) System.
Catherine Seme, M.S.
LinkedInExperience: Sr. Director, Clinical Affairs · Inquis Medical, Inc.
Sr. Director, Clinical Affairs at Inquis Medical, Inc. since 2023 and former Director, Clinical Affairs at Vesper Medical, Inc. (acquired by Philips) (2020–2023). The profile describes 14 years in medical device start-ups and building and leading teams that meet clinical trial milestones; it also lists Clinical Affairs Project Manager at Intact Vascular (2015–2018).
Chuck Cain
LinkedInExperience: Director Clinical Affairs · Philips
Former Director Clinical Affairs at Philips (2021–2024), where the profile says this person oversaw clinical evidence strategies and global clinical research execution. The profile also lists Associate Director, Clinical Development (2020–2021) and Manager Clinical Operations Manager Clinical Research (2013–2018) at Philips Respironics.
Eric Fernandez MD
LinkedInExperience: Director Clinical Affairs · Cordis
Director Clinical Affairs at Cordis since 2026, where the profile says this person leads the global clinical affairs strategy for the company's vascular and endovascular portfolio and directs a clinical affairs organization. Former Sr. Director Global Clinical Research HST at Baxter International Inc. (2023–2026) and Director of Clinical Research at Penumbra, Inc. (2022–2023).
Kathleen Calderon
LinkedInExperience: Sr. Director Medical & Clinical Affairs · Encompass Technologies
Former Sr. Director Medical & Clinical Affairs at Encompass Technologies (2022–2026), where the profile says this person led clinical operations for Early Feasibility (EFS) and Investigational Device Exemption (IDE) studies globally. Former Director of Clinical & Market Affairs at Vesalio (2018–2022), a role the profile says managed pre-market IDE studies in the US and EU.
Linda A. Clark
LinkedInExperience: Vice President of Clinical Affairs · Lungpacer Medical
Former Vice President of Clinical Affairs at Lungpacer Medical (2015–2021), Global Director of Clinical Affairs at LoneStar Heart, Inc. (2013–2015), Global Director, Clinical Affairs at ZOLL Respicardia (2011–2013) and Senior Director, Clinical Affairs at Paracor Medical (2005–2011). The profile mentions capability in IDE clinical trial design.
Mason Liu
LinkedInExperience: Director of Clinical Affairs · Medtronic
Director of Clinical Affairs at Medtronic since 2021 and former Associate Director of Clinical Affairs there (2015–2021). The profile says this person is responsible for clinical affairs at Medtronic, including cardiovascular, and specializes in global clinical trials and clinical strategy for Class II and Class III medical devices; it also lists Clinical Trial Manager at Boston Scientific (2009–2015).
Sara Lam
LinkedInExperience: Senior Director, Clinical Affairs · Solventum (formally 3M Healthcare Business Group)
Senior Director, Clinical Affairs at Solventum (formally 3M Healthcare Business Group) since 2024. Former Global Director, Clinical Affairs (2022–2024) and Director, Clinical Affairs (2019–2022) at 3M; the profile describes nearly 20 years leading global clinical research and evidence planning.
Sundeep Master
LinkedInExperience: Sr. Director, Clinical Affairs · Intuitive
Sr. Director, Clinical Affairs at Intuitive since 2025. At Intuitive the profile also lists Director, Clinical Affairs - Endoluminal (2022–2025), Senior Manager, Clinical Affairs (2020–2022) and Manager II, Clinical Affairs (2018–2020), and it describes monitoring the publication landscape through regular review of scientific literature.
Choose the right perspective
Match the person's device type and risk class to yours, since an early feasibility study for a novel implant differs from post-market evidence work for an established product line. Also consider company size, and ask whether the person built a clinical team at a start-up or ran studies inside a large device company.
Questions to take into the conversation
- 01How do you decide whether a device needs a new clinical study or can rely on existing evidence?
- 02What makes an IDE study design hold up with regulators while still being practical for sites to enroll?
- 03How do you choose and manage clinical sites and outside research organizations for a device trial?
Reaching medical device clinical affairs experts
How can I contact one of these medical device clinical affairs experts?
Pick one of the 10 people on this page and choose "Book a paid call", or describe your project to find others. You offer a fee for a 15-minute call or a written answer, Instant Expert finds the person's work email and sends the invitation, and they decide whether to accept. The list covers 10 companies, including Integra LifeSciences; Pulmonx Corporation and Inquis Medical, Inc., based on profile data retrieved on October 4, 2026. Being listed here doesn't mean someone has agreed to take calls.
How much does it cost to reach medical device clinical affairs experts?
You choose the offer, starting at $5 per person. It includes Instant Expert's 20% fee, so an offer that pays the person $100 costs you $125. You're charged only when the person books the call or sends the answer.
What if they don't reply?
You pay nothing. Instant Expert sends follow-up reminders, and if the person hasn't booked or answered within 7 days, the request expires and any hold on your card is released. You can invite several of the 10 people on this list at once and cap your total spend, so you pay only for the ones who accept.
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot and may describe past or present roles. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.
Request a correction or removal